Fny Investment Advisers, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Fny Investment Advisers, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Jan 22, 2019	SELL	$31.54 - $46.67 $2,365 - $3,500	-75 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$38.0 - $51.1 $76 - $102	-2 Reduced 2.6%	75 $2,000
Q3 2018 Oct 29, 2018	BUY	$38.0 - $51.1 $1,140 - $1,533	30 Added 63.83%	77 $2,000
Q2 2018 Jul 18, 2018	BUY	$38.7 - $50.15 $1,818 - $2,357	47 New	47 $2,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.